Andrew Cheng
2021
In 2021, Andrew Cheng earned a total compensation of $4.5M as President and Chief Executive Officer at Akero Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,239 |
|---|---|
| Option Awards | $3,571,922 |
| Salary | $569,525 |
| Total | $4,454,686 |
Cheng received $3.6M in option awards, accounting for 80% of the total pay in 2021.
Cheng also received $313.2K in non-equity incentive plan and $569.5K in salary.
Rankings
In 2021, Andrew Cheng's compensation ranked 2,978th out of 12,406 executives tracked by ExecPay. In other words, Cheng earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,978 out of 12,406 | 76th |
Division Manufacturing | 1,192 out of 5,492 | 78th |
Major group Chemicals And Allied Products | 479 out of 2,368 | 80th |
Industry group Drugs | 422 out of 2,089 | 80th |
Industry Pharmaceutical Preparations | 287 out of 1,536 | 81st |
Source: SEC filing on April 28, 2023.
Cheng's colleagues
We found four more compensation records of executives who worked with Andrew Cheng at Akero Therapeutics in 2021.